Details.
Dupilumab is a medication indicated for moderate-to-severe atopic dermatitis and severe asthma in Australia. It is administered by subcutaneous injection using a pre-filled syringe, initially every 2 weeks. Further dosing and frequency may be changed by your doctor depending on your condition and response to treatment. Clinic nurses or your GP can provide guidance with self-injection or administer the injection. Treatment duration depends on effectiveness and tolerability, and follow-up appointments are required to monitor response and potential side effects.